Your browser doesn't support javascript.
loading
Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy.
Tan, Wei Shen; Koelker, Mara; Campain, Nicholas; Cole, Alexander P; Labban, Muhieddine; Mossanen, Matthew; Barod, Ravi; Kibel, Adam S; Chang, Steven L; Bex, Axel; Trinh, Quoc-Dien.
Afiliação
  • Tan WS; Division of Surgery and Interventional Science, Department of Urology, University College London, London, UK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Koelker M; Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Campain N; Department of Urology, Royal Devon and Exeter Hospital, Exeter, UK.
  • Cole AP; Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Labban M; Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Mossanen M; Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Barod R; The Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK.
  • Kibel AS; Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chang SL; Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bex A; Division of Surgery and Interventional Science, Department of Urology, University College London, London, UK; The Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK.
  • Trinh QD; Center for Surgery and Public Health, Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: qtrinh@bwh.harvard.edu.
Eur Urol Focus ; 9(2): 333-335, 2023 03.
Article em En | MEDLINE | ID: mdl-36241545
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur Urol Focus Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur Urol Focus Ano de publicação: 2023 Tipo de documento: Article